clinical trial · NCT06515730
Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction
Karolinska Institutet·phase4·recruiting·n = 212
Left Ventricular ThrombusAcute Myocardial InfarctionApixabanWarfarin
brief summary
The optimal anticoagulant for the treatment of left ventricular (LV) thrombus following acute myocardial infarction (AMI) is unclear. The aim of this multicenter randomized study is to evaluate the efficacy of apixaban versus warfarin with respect to thrombus resolution in patients with LV thrombus after AMI.
started
Apr 8, 2025
primary completion
Apr 8, 2028
completion
Jul 1, 2028
last updated
Jul 1, 2025
official title
RandomizEd compariSOn of Apixaban Versus Warfarin in Patients With Left VEntricular Thrombus After Acute Myocardial Infarction (RESOLVE-AMI)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol